drugset / Trial / NCT00504439
A Study To Evaluate The Safety And Tolerability Of SB-656933-AAA Following Repeated Doses In Healthy Adult Subjects
RandomizedParallel-groupTreatment
Summary
To assess safety of SB-656933 following repeat dosing for 14 days.
Timeline
- Start
- 2007-06-04
- Primary completion
- 2007-09-06
- Completion
- 2007-09-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ELUBRIXIN | Small molecule | 20 mg | Oral |
| Subject | ELUBRIXIN | Small molecule | 50 mg | Oral |
| Subject | ELUBRIXIN | Small molecule | 100 mg | Oral |
| Subject | Simvastatin | Small molecule | 40 mg | — |